by Summary:
'I think there’s a high chance that it will work based on other things that we have done with this type of vaccine It has a 80% chance of working, says Professor Sarah Gilbert, so much so, that she has advised the government to start manufacturing now so it will be ready as soon as it passes its trails. Sarah Gilbert is a professor of vaccinology at the University of Oxford and leads a team of researchers in developing a vaccine for the coronavirus, which has so far infected more than 1.7 million worldwide. Coronavirus vaccine could be ready by September, says Oxford professor working on trials
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
'I think there’s a high chance that it will work based on other things that we have done with this type of vaccine It has a 80% chance of working, says Professor Sarah Gilbert, so much so, that she has advised the government to start manufacturing now so it will be ready as soon as it passes its trails. Sarah Gilbert is a professor of vaccinology at the University of Oxford and leads a team of researchers in developing a vaccine for the coronavirus, which has so far infected more than 1.7 million worldwide. Coronavirus vaccine could be ready by September, says Oxford professor working on trials
Topics:
Mike Norman considers the following as important:
This could be interesting, too:
New Economics Foundation writes Is the Labour government delivering on its promises?
Robert Vienneau writes Why Is Marginalist Economics Wrong?
John Quiggin writes Dispensing with the US-centric financial system
New Economics Foundation writes Whose growth is it anyway?
'I think there’s a high chance that it will work based on other things that we have done with this type of vaccine
It has a 80% chance of working, says Professor Sarah Gilbert, so much so, that she has advised the government to start manufacturing now so it will be ready as soon as it passes its trails.
Sarah Gilbert is a professor of vaccinology at the University of Oxford and leads a team of researchers in developing a vaccine for the coronavirus, which has so far infected more than 1.7 million worldwide.